Fluvoxamine is a potent inhibitor of tacrine metabolism

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 767卷 / 1期
关键词：
Public Health; Plasma Concentration; Single Dose; Treatment Regimen; Clinical Pharmacology;
D O I：
10.2165/00128415-199907670-00004
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [31] Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics
    Meena, Virendra Kumar
    Chaturvedi, Shubhra
    Sharma, Rakesh Kumar
    Mishra, Anil Kumar
    Hazari, Puja Panwar
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2296 - 2308
  • [32] FLUVOXAMINE, A SPECIFIC 5-HYDROXYTRYPTAMINE UPTAKE INHIBITOR
    CLAASSEN, V
    DAVIES, JE
    HERTTING, G
    PLACHETA, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) : 505 - 516
  • [33] Discovery of novel and potent tacrine derivatives as CDK2 inhibitors
    Huang, Yaoguang
    Li, Deping
    Xu, Chang
    Zhu, Chengze
    Wu, Limeng
    Shen, Meiling
    Li, Yue
    Jiang, Xiaowen
    Liu, Wenwu
    Zhao, Qingchun
    Ren, Tianshu
    NEW JOURNAL OF CHEMISTRY, 2022, 46 (43) : 20972 - 20984
  • [34] Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors
    Carlier, PR
    Du, DM
    Han, YF
    Liu, J
    Pang, YP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2335 - 2338
  • [35] Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor
    Lin, JH
    Chiba, M
    Balani, SK
    Chen, IW
    Kwei, GYS
    Vastag, KJ
    Nishime, JA
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (10) : 1111 - 1120
  • [36] METABOLISM OF 1-AMINOETHYLPHOSPHINATE GENERATES ACETYLPHOSPHINATE, A POTENT INHIBITOR OF PYRUVATE-DEHYDROGENASE
    LABER, B
    AMRHEIN, N
    BIOCHEMICAL JOURNAL, 1987, 248 (02) : 351 - 358
  • [37] The pharmacokinetics and metabolism of HMPL012, a novel potent inhibitor targeting multiple kinases
    Wang, Jian
    Gu, Yi
    Xue, Weifang
    Zhang, Li
    Ke, Li
    Hu, Zheyi
    Zhang, Weihan
    Su, Weiguo
    Sai, Yang
    DRUG METABOLISM REVIEWS, 2011, 43 : 89 - 90
  • [38] The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects
    Halpin, RA
    Porras, AG
    Geer, LA
    Davis, MR
    Cui, DH
    Doss, GA
    Woolf, E
    Musson, D
    Matthews, C
    Mazenko, R
    Schwartz, JI
    Lasseter, KC
    Vyas, KP
    Baillie, TA
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) : 684 - 693
  • [39] Fluvoxamine alters the activity of energy metabolism enzymes in the brain
    Ferreira, Gabriela K.
    Cardoso, Mariane R.
    Jeremias, Isabela C.
    Goncalves, Cinara L.
    Freitas, Karolina V.
    Antonini, Rafaela
    Scaini, Giselli
    Rezin, Gislaine T.
    Quevedo, Joao
    Streck, Emilio L.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2014, 36 (03) : 220 - 226
  • [40] A potent farnesyltransferase inhibitor
    Tranter, D
    DRUG DISCOVERY TODAY, 2001, 6 (03) : 157 - 157
12345